The present invention relates to isolated or purified or partially purified peptide derived molecules having the following general formula (S1): X-[(Pro).sub.n-His-Pro-His-Ala-Arg-Ile-Lys].sub.m-Y. The peptides are for medical use, in particular as anti-tumoral agents.

The present invention relates to isolated or purified or partially purified peptide derived molecules having the following general formula (S1): X-[(Pro).sub.n-His-Pro-His-Ala-Arg-Ile-Lys].sub.m-Y. The peptides are for medical use, in particular as anti-tumoral agents.

The present invention relates to a targeting module comprising a chemically synthesized peptide binding moiety specific for a human cell surface protein or protein complex, a kit comprising the targeting module and a vector or a cell comprising a nucleic acid encoding a universal chimeric antigen receptor and the use for the treatment of cancer, infections and autoimmune disorders.

Provided herein are ionic self-assembling peptides, pharmaceutical compositions comprising the peptides, and methods of using and making the same.

Provided herein are ionic self-assembling peptides, pharmaceutical compositions comprising the peptides, and methods of using and making the same.

The invention discloses a polypeptide for topical treatment on skin damages resulting from various causes such as burns, wounds or cuts. The polypeptide topical drugs in different dosage forms have good therapeutic effect on scald models and trauma models of animals with little toxic and side effects, and is an innovative drug with good development prospects, and is effective in topical application in treating skin damages resulting from various causes such as burns, wounds or cuts; safe; low toxic and quality controllable.

The invention discloses a polypeptide for topical treatment on skin damages resulting from various causes such as burns, wounds or cuts. The polypeptide topical drugs in different dosage forms have good therapeutic effect on scald models and trauma models of animals with little toxic and side effects, and is an innovative drug with good development prospects, and is effective in topical application in treating skin damages resulting from various causes such as burns, wounds or cuts; safe; low toxic and quality controllable.

The disclosures herein relate a method of treating coronavirus infections. More specifically disclosed herein are peptides effective as apelin receptor agonists. Also disclosed herein are peptides effective in the treatment of acute respiratory distress syndrome (ARDS) induced by COVID-19.

The disclosures herein relate a method of treating coronavirus infections. More specifically disclosed herein are peptides effective as apelin receptor agonists. Also disclosed herein are peptides effective in the treatment of acute respiratory distress syndrome (ARDS) induced by COVID-19.

A vaccine construct comprising an antigenic PCSK9 peptide and an immunogenic carrier, and methods of using the same that are effective to lower blood cholesterol levels in a mammal and treat dyslipidemias and related disease states in a mammal without the frequency of administration required by passive immunity strategies.